Secondary pre-leukaemia and etoposide
- 16 November 1991
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 338 (8777) , 1269-1270
- https://doi.org/10.1016/0140-6736(91)92133-m
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumoursThe Lancet, 1991
- Myeloid neoplasia in children treated for solid tumoursThe Lancet, 1990
- Hematologic Neoplasia Associated with Primary Mediastinal Germ-Cell TumorsNew England Journal of Medicine, 1990
- Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial.Journal of Clinical Oncology, 1990
- Isochromosome of Chromosome 12: Clinically Useful Marker for Male Germ Cell TumorsJNCI Journal of the National Cancer Institute, 1989
- Leukemic differentiation of a mediastinal germ cell tumorGenes, Chromosomes and Cancer, 1989
- Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid LeukemiaNew England Journal of Medicine, 1989
- Mediastinal germ cell tumors and histiocytosisHuman Pathology, 1988
- Short‐course Etoposide, Bleomycin and Cisplatin in the Treatment of Metastatic Germ Cell Tumours. Appraisal of its Potential as Adjuvant Chemotherapy for Stage 1 Testis TumoursBritish Journal of Urology, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987